C. Michael Gibson
About
In The Last Decade
C. Michael Gibson
213 papers receiving 14.6k citations
Hit Papers
Peers
Comparison fields: 5 of 157
- Cardiology and Cardiovascular Medicine 11.8k
- Surgery 6.8k
- Radiology, Nuclear Medicine and Imaging 3.9k
- Internal Medicine 2.2k
- Pulmonary and Respiratory Medicine 1.2k
Countries citing papers authored by C. Michael Gibson
This map shows the geographic impact of C. Michael Gibson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Michael Gibson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Michael Gibson more than expected).
Fields of papers citing papers by C. Michael Gibson
This network shows the impact of papers produced by C. Michael Gibson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Michael Gibson. The network helps show where C. Michael Gibson may publish in the future.
Co-authorship network of co-authors of C. Michael Gibson
This figure shows the co-authorship network connecting the top 25 collaborators of C. Michael Gibson. A scholar is included among the top collaborators of C. Michael Gibson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Michael Gibson. C. Michael Gibson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 9 | |
| 5 | 26 | |
| 6 | 22 | |
| 7 | 20 | |
| 8 | 31 | |
| 9 | 2 | |
| 10 | 60 | |
| 11 | The determinants of side branch compromise after main vessel stenting in coronary bifurcation lesions. | 10 |
| 12 | 66 | |
| 13 | Abstract 12776: Non-ST-segment Elevation Acute Coronary Syndromes Patients without Angiographically Detected Obstructive Coronary Artery Disease are Low-risk but Not No-risk: A Meta-analysis of 8 Trials of 37,101 Patients | 1 |
| 14 | Abstract 13146: The Benefit of Transferring STEMI Patients for PCI Compared with Administration of Onsite Fibrinolytic Declines as Delays Increase | 2 |
| 15 | 4 | |
| 16 | Therapeutic margin of safety with weight-optimized dosing of tenecteplase | 1 |
| 17 | 5 | |
| 18 | Enoxaparin with or without GPIIb/IIIa inhibition as reperfusion strategy in ST-segment elevation MI - results of the ENTIRE-TIMI 23 trial | 1 |
| 19 | Abciximab improves both epicardial flow and myocardial reperfusion in ST elevation myocardial infarction: a TIMI 14 analysis | 8 |
| 20 | TNK-tissue plasminogen activator compared with front-loaded tissue plasminogen activator in acute myocardial infarction: primary results of the TIMI 10B trial | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.